ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB:GNLK.OB), (“the Company,” or “GeneLink”), a leading consumer genomics biotech company, today reported that it has closed two separate private placements for gross proceeds of $2,418,500. The first private placement closed in January 2009 and the Company received initial funding on the second private placement on February 27, 2009.
